О Д Л У К А за утврдување на предлог референтни цени на лекови. Член 1

Size: px
Start display at page:

Download "О Д Л У К А за утврдување на предлог референтни цени на лекови. Член 1"

Transcription

1 Врз основа на члeн 56 став 1 точка 14, а во врска со член 54 став 1, точка 8, член 63а, 63б и 63в од Законот за здравственото осигурување ( Службен весник на Република Македонија број 25/2000, 34/2000, 96/2000, 50/2001, 11/2002, 31/2003, 84/2005, 37/2006, 18/2007, 36/2007, 82/2008, 98/2008, 6/2009, 67/2009, 50/2010, 156/2010, 53/2011, 26/2012, 16/2013 и 91/2013 ), и член 16 и 17 од Правилникот за утврдување на критериуми и постапка за одредување на референтни цени на лекови ( Службен весник на Република Македонија број 158/2009 и 138/2010), Управниот одбор на Фондот за здравствено осигурување на Македонија на седницата одржана на година, донесе О Д Л У К А за утврдување на предлог референтни цени на лекови Член 1 Со оваа одлука се утврдуваат предлог референтни цени на лекови кои се на Листата на лекови кои паѓаат на товар на Фондот за здравствено осигурување на Македонија. Член 2 Се утврдуваат следните предлог референтни цени на лекови кои се на Листата на лекови кои паѓаат на товар на Фондот за здравствено осигурување на Македонија: ATЦ код Генеричко име-inn Фармацевтска дозажна форма Јачина Заштитено име на лекот Производител Пакување Предлог референтна цена по единица со 5% ДДВ Предлог референтна цена по пакување со 5% ДДВ A07AX03 Nifuroxazide Капсули C01AA08 Metildigoxin Таблети 0,1mg C02CA04 Doxazosin Таблети 4mg H01BA02 Desmopressin Назален спреј 0,1mg/ml H02AB04 Methylprednisolone Таблети 4mg J05AF05 Lamivudine Таблети/ филм ENTEROFURYL капс.16 x BOSNALIJEK 16 9,33 149,00 FURAL капс.20 x ALKALOID 20 9,33 187,00 PLITOP табл. 50 x 0,1mg PLIVA 50 2,21 110,00 KAMIREN табл.30 x 4mg KRKA 30 6,80 204,00 MINIRIN Назален спреј 0,1mg/ml (5ml) (50 дози)(10mcg/doza) FERRING , ,00 NIRYPAN табл. 20 x 4mg JUGOREMEDIJA 20 3,96 79,00 N02AX02 Tramadol Капсули/ / филм ZEFFIX филм.обл.табл. 28 x GSK 28 95, ,00 TRAMADOL R табл. 30 x KRKA 30 6,62 198,00 TRODON табл. 10 x HEMOFARM 10 6,62 66,00

2 N02AX02 Tramadol капсули/ / филм N03AF01 Carbamazepine Таблети R03AK06 Salmeterol, fluticasone Прашок за инхалирање R03BA05 Fluticasone Аеросол 50mcg + 100mcg 50mcg/ доза S01BA01 Dexamethasone Капки за очи 1mg/ml B01AB06 B01AB06 Nadroparin Nadroparin 5700IU 7600IU B01AC17 Tirofiban Инјекции 0,25mg/ml B03XA01 Erythropoietin Инјекции 1000IU B03XA01 Erythropoietin Инјекции 3000IU B05BA01 Aminokiselini раствор за (инфузија) 15% (500ml) C08CA06 Nimodipine Инјекции 10mg/50ml TRODON капс. 10 x HEMOFARM ,00 KARBAPIN табл.50 x CARBAMAZEPIN табл.50 x TEGRETOL табл.50 x HEMOFARM 50 REMEDICA 50 PLIVA 50 EPIAL табл.50 x ALKALOID 50 GALEPSIN (CARBAMAZEPIN) GALENIKA 50 табл.50 x SERETIDE DISKUS прашок за инхалирање 50mcg+100mcg (60 дози) GSK , ,00 FLIXOTIDE аеросол 50mcg/доза (120 дози) GSK 1 380,44 380,00 MAXIDEX капки за очи 1mg/ml (5ml) ALCON 1 86,55 87,00 FRAXIPARINE раствор за IU/0,6ml (0,6ml) GSK , ,00 FRAXIPARINE раствор за IU/0,8ml(0,8ml) GSK , ,00 AGGRASTAT инјекции 0.25 mg /ml (50ml) MSD , ,00 EPREX инјекции1000 IU/0,5ml (0,5ml) JANSSEN CILAG 6 277, ,00 EPREX инјекции 3000 IU/0,3ml JANSSEN CILAG 6 821, ,00 AMINOSOL 15% раствор за (инфузија) 15% (500ml) HEMOFARM 1 313,24 313,00

3 H01CB02 Octreotide Инјекции 0,5mg/ml H04AA01 Glucagon Лио шишенца 1mg J01CR01 Ampicillin + sulbactam Инјекции ( )mg NIMOTOP S инјекции 10mg/50ml BAYER 1 559,36 559,00 SANDOSTATIN инјекции 0,5mg/ml NOVARTIS , ,00 GLUCAGEN HYPO KIT Лио шишенца 1mg (1ml) NOVO NORDISK 1 880,78 881,00 J01DD04 Ceftriaxone Инјекции 1g J01GB01 Tobramycin инхалирање 75mg/ml J01GB06 Amikacin Инјекции J01XB01 Colistin Инјекции IU L01BC05 Gemcitabine Инјекции 500mg L01CA02 Vincristine Инјекции 1mg L01CD02 Docetaxel Инјекции 140mg/7ml AMPISID инјекции ( )mg (3,5ml) NEVAKSON инјекции 1g (3,5ml)(I.M) NEVAKSON инјекции 1g (10ml)(I.V) BIOTRAKSON инјекции 1g Mustafa Nevzat Ilac. Sanayii A.S. 1 74,30 74,00 NEVZAT ILAC 1 42,80 43,00 NEVZAT ILAC 1 42,80 43,00 PHARMACEUTI CALS WORKS POLPHARMA 1 42,80 43,00 PANTOXON инјекции 1g/3,5ml MITIM 1 42,80 43,00 TERCEF инјекции 1g BALKANPHARM A 5 42,80 214,00 LENDACIN инјекции 1g LEK 10 42,80 428,00 LONGACEPH инјекции 1g GALENIKA 10 42,80 428,00 NEVAKSON инјекции 1g NEVZAT ILAC 20 42,80 856,00 CEFTRIAXONE PANPHARMA инјекции 1g PANPHARMA 25 42, ,00 AZARAN инјекции 1g HEMOFARM 50 42, ,00 BRAMITOB раствор за инхалирање 75mg/ml (300mg/4ml) CHIESI PHARMACEUTI CI , ,00 AMIKACIN инјекции (2ml) GALENIKA 10 33,81 338,00 COLOMYCIN инјекции IU FOREST LABORATORIES 1 372,00 372,00 GEMCITABIN концентрат за раствор за инфузија 500mg (50ml) EBEWE , ,00 SINDOVIN инјекции 1mg/10ml S.C.SINDAN PHARMA SRL 1 231,77 232,00

4 L01DB06 Idarubicin Инјекции 5mg L01DB06 Idarubicin Инјекции 10mg L01DB06 Idarubicin Инјекции 20mg L02BB03 Bicalutamide Филм 150mg N07AA02 Pyridostigmine Таблети 60mg R07AA02 V03AC02 Surfaktant, prirodni fosfolipidi Инјекции 25mg/ml Deferiprone / / филм 500mg DOCETAXEL ACTAVIS инјекции 140mg/7ml ZAVEDOS инјекции 5mg IDAMEN инјекции 5mg ZAVEDOS инјекции 10mg IDAMEN инјекции 10mg IDAMEN инјекции 20mg (20ml) S.C SINDAN PHARMA S.R.L , ,00 ACTAVIS Italy S.p.A , ,00 NEVZAT , ,00 ACTAVIS Italy S.p.A , ,00 NEVZAT , ,00 NEVZAT , ,00 CASODEX филм обл. табл. 28x150mg ASTRAZENECA , ,00 BICUSAN филм обл. табл. 28x150mg SYNTON , ,00 BICUSAN филм обл. табл. 30x150mg SYNTON , ,00 MESTINON табл.20x60mg MESTINON табл.150x60mg ICN Polfa Rzesow S.A ,24 225,00 ICN Polfa Rzesow S.A , ,00 SURVANTA инјекции 25mg/1ml (8ml) ABBOT , ,00 FERRIPROX филм обл.табл.100 x 500mg Chiesi FARMACEUTICI SPA , ,00

5 Член 3 Оваа одлука влегува во сила со денот на донесувањето, и ќе се објави на web страната на Фондот. Во рок од 15 дена од објавувањето, носителите на решениja за ставање во промет на лековите за кои се утврдени предлог референтни цени може да дадат забелешки на одлуката. Број: УПРАВЕН ОДБОР година Претседател, Скопје Ангел Митевски Усвоено од Управниот одбор на

PAYS D'ORIGINE NOM DOSAGE FORME NR ST LABORATOIRE A-CNOTREN 20MG 30 SOFT CAPSULES 218180/09 * GAP S.A FOR PHARMATHEN S.A GRECE ACUVAIL 0.

PAYS D'ORIGINE NOM DOSAGE FORME NR ST LABORATOIRE A-CNOTREN 20MG 30 SOFT CAPSULES 218180/09 * GAP S.A FOR PHARMATHEN S.A GRECE ACUVAIL 0. NOM DOSAGE FORME NR ST LABORATOIRE PAYS D'ORIGINE A-CNOTREN 20MG 30 SOFT CAPSULES 218180/09 * GAP S.A FOR PHARMATHEN S.A GRECE ACUVAIL 0.45% 0.4ML X 30 SINGLE USE VIALS 097674/11 ALLERGAN SALES LLC USA

More information

Legal and Institutional Framework of Life Insurance in the Republic of Macedonia. Abstract

Legal and Institutional Framework of Life Insurance in the Republic of Macedonia. Abstract Biljana Petrevska 1, PhD Legal and Institutional Framework of Life Insurance in the Republic of Macedonia Abstract Life insurance is the most common type of insurance in the world, mainly because of its

More information

SEIZURES AFTER USE AND ABUSE OF TRAMADOL. University Toxicology Clinic, Skopje, R. Macedonia 2. University Neurology Clinic, Skopje, R.

SEIZURES AFTER USE AND ABUSE OF TRAMADOL. University Toxicology Clinic, Skopje, R. Macedonia 2. University Neurology Clinic, Skopje, R. Prilozi, Odd. biol. med. nauki, MANU, XXXIII, 1, s. 313 318 (2012) Contributions, Sec. Biol. Med. Sci., MASA, XXXIII, 1, p. 313 318 (2012) ISSN 0351 3254 UDC: 615.212.3.065:616.853 CASE REPORT SEIZURES

More information

THREE PERIODS OF HEALTH SYSTEM REFORMS IN THE REPUBLIC OF MACEDONIA (1991 2011)

THREE PERIODS OF HEALTH SYSTEM REFORMS IN THE REPUBLIC OF MACEDONIA (1991 2011) Prilozi, Odd. biol. med. nauki, MANU, XXXIII, 2, s. 175 189 (2012) Contributions, Sec. Biol. Med. Sci., MASA, XXXIII, 2, p. 175 189 (2012) ISSN 0351 3254 UDK: 614.2:005.591.4(497.7)"1991/2011" THREE PERIODS

More information

supplement 18 PAYS D'ORIGINE NOM DOSAGE FORME NR ST LABORATOIRE 4ML CONCENTRATE FOR SOLUTION FOR INFUSION x 1VIAL

supplement 18 PAYS D'ORIGINE NOM DOSAGE FORME NR ST LABORATOIRE 4ML CONCENTRATE FOR SOLUTION FOR INFUSION x 1VIAL supplement 18 NOM DOSAGE FORME NR ST LABORATOIRE PAYS D'ORIGINE ACTEMRA 80MG/4ML 4ML CONCENTRATE FOR SOLUTION FOR INFUSION x 218156/09 * CHUGAI PHARMA MANUFACTURING CO LTD FOR F.HOFFMANN-LA ROCHE LTD -

More information

Implementation of Supply Chain Management (SCM) in pharmaceutical company, general principles and case study

Implementation of Supply Chain Management (SCM) in pharmaceutical company, general principles and case study Macedonian pharmaceutical bulletin, 60 (2) 75-82 (2014) ISSN 1409-8695 UDC: 658.86/.87:661.12 Case study Implementation of Supply Chain Management (SCM) in pharmaceutical company, general principles and

More information

EX.VTP.MK.02.01 FAVV-AFSCA 1/5

EX.VTP.MK.02.01 FAVV-AFSCA 1/5 ВЕТЕРИНАРНО ЗДРАВСТВЕН СЕРТИФИКАТ ЗА МЕСО ОД ЖИВИНА ЗА УВОЗ ВО РЕПУБЛИКА МАКЕДОНИЈА Health Certificate for meat of poultry (POU) for dispatch to the Republic of Macedonia Certificat sanitaire pour les

More information

70 th fiaf Congress 04 th 10 th May 2014. Skopje. Newsletter No.2

70 th fiaf Congress 04 th 10 th May 2014. Skopje. Newsletter No.2 Newsletter No.2 70 th fiaf Congress 04 th 10 th May 2014 Skopje Министерство за култура на Република Македонија Ministry of Culture of the Republic of Macedonia Кинотека на Македонија Cinematheque of Macedonia

More information

Prontuario Terapeutico Ospedaliero

Prontuario Terapeutico Ospedaliero Prontuario Terapeutico Ospedaliero Pagina 1 di 56 Impostazione Il presente Prontuario Terapeutico Ospedaliero, suddiviso per gruppi terapeutici, comprende farmaci anche a brevetto scaduto, dei quali è

More information

Marketing authorisations granted in March 2016

Marketing authorisations granted in March 2016 PL 10321/0204 01/03/2016 RESOLUTION CHEMICALS LIMITED HYDROCORTISONE 10 MG TABLETS HYDROCORTISONE 10.00 MILLIGRAMMES POM PL 10321/0205 01/03/2016 RESOLUTION CHEMICALS LIMITED HYDROCORTISONE 20 MG TABLETS

More information

Parte I: Informazioni sulla partita spedita /Дел I: Детали за испратената пратка

Parte I: Informazioni sulla partita spedita /Дел I: Детали за испратената пратка CERTIFICATO VETERINARIO ВЕТЕРИНАРНО ЗДРАВСТВЕН СЕРТИФИКАТ Health Certificate MP-PR/ MP-PR per i prodotti a base di carne e stomaci, vesciche ed intestini trattati destinati all esportazione verso la Repubblica

More information

Melbourne 21st - 30th September. Perth 6th October. Newcastle 6th October. Auckland 13th - 14th October. Sydney 24th - 25th November

Melbourne 21st - 30th September. Perth 6th October. Newcastle 6th October. Auckland 13th - 14th October. Sydney 24th - 25th November MFF2012_A2_poster.indd 2 9/16/2012 9:54:24 PM Australasian premiere of Milcho Manchevski s award winning masterpiece Mothers Melbourne 21st - 30th September Perth 6th October Newcastle 6th October Auckland

More information

DPC AGGIORNATO AL 25/04/2011 PER SPECIALITA'

DPC AGGIORNATO AL 25/04/2011 PER SPECIALITA' DPC AGGIORNATO AL 2/04/20 PER SPECIALITA' 03682029 ABILIFY CPR. 0MG. N0AX2 ARIPIPRAZOLO 2 0368203 ABILIFY CPR. MG. N0AX2 ARIPIPRAZOLO 3 0368207 ABILIFY CPR. MG. N0AX2 ARIPIPRAZOLO 4 03682094 ABILIFY CPR.

More information

MEDICAL COLLEGE & HOSPITAL IN DOOR ESSENTIAL DRUG LIST

MEDICAL COLLEGE & HOSPITAL IN DOOR ESSENTIAL DRUG LIST ANNEXURE - D MEDICAL COLLEGE & HOSPITAL IN DOOR ESSENTIAL DRUG LIST Bihar EDL 1. Anaesthetics 1.1 Local Anaesthetics Bupivacaine Injection Plain-0.5% (5mg/ml) Hydrochloride Heavy-0.5% + 80mg/ml Dextrose

More information

. g .,, . . , Applicability of

More information

Programming the Microchip Pic 16f84a Microcontroller As a Signal Generator Frequencies in Railway Automation

Programming the Microchip Pic 16f84a Microcontroller As a Signal Generator Frequencies in Railway Automation 988 Programming the Microchip Pic 16f84a Microcontroller As a Signal Generator Frequencies in Railway Automation High School of Transport "Todor Kableshkov" 1574 Sofia, 158 Geo Milev str. Ivan Velev Abstract

More information

PPRS 2014 analysis of growth in spend of branded medicines. DH Leading the nation s health and care

PPRS 2014 analysis of growth in spend of branded medicines. DH Leading the nation s health and care PPRS 2014 analysis of growth in spend of branded medicines March 2015 Executive Summary IMS Health data shows growth in spend in 2014 (compared to 2013) of 8.2% on branded medicines. This is higher than

More information

Meloxicam 15 Mg High Blood Pressure

Meloxicam 15 Mg High Blood Pressure Meloxicam 15 Mg High Blood Pressure 1 para que serve o remedio meloxicam 7 5mg 2 meloxicam 7.5 mg cost 3 meloxicam 0.5 mg/ml 4 meloxicam 75 mg used 5 meloxicam tablets 7.5 mg for dogs 6 thuoc meloxicam

More information

MACEDONIAN STOCK EXCHANGE: DEVELOPMENT OF INVESTMENT BANKING AS OPPORTUNITY FOR LARGER INVESTMENTS IN NATIONAL ECONOMY

MACEDONIAN STOCK EXCHANGE: DEVELOPMENT OF INVESTMENT BANKING AS OPPORTUNITY FOR LARGER INVESTMENTS IN NATIONAL ECONOMY Review (accepted January 26, 2011) MACEDONIAN STOCK EXCHANGE: DEVELOPMENT OF INVESTMENT BANKING AS OPPORTUNITY FOR LARGER INVESTMENTS IN NATIONAL ECONOMY Nadica Ivanovska 1 Zoran Ivanovski Abstract: Institutional

More information

Pharma RepTrak 2015 The World s Most Reputable Pharmaceutical Companies

Pharma RepTrak 2015 The World s Most Reputable Pharmaceutical Companies Pharma RepTrak 2015 The World s Most Reputable Pharmaceutical Companies The Pharma Industry s Reputation in the Eyes of the General Public A Reputation Study with Consumers in 15 Countries RepTrak is a

More information

J_Code To NDC Billing Cross Reference Guide

J_Code To NDC Billing Cross Reference Guide J_Code To Billing Cross Reference Guide J0129 Injection, abatacept, 10 mg GENERIC J0129 UN 250 MG 250 MG 25 ABATACEPT/MALTOSE J0150 6 MG Injection adenosine 6 MG GENERIC J0150 ML 3 MG/ML 3 MG ML 1 0.5

More information

Importance. of the pharmaceutical industry for Polish economy

Importance. of the pharmaceutical industry for Polish economy Polski Związek Pracodawców Przemysłu Farmaceutycznego october 2011 Importance of the pharmaceutical industry for Polish economy The domestic pharmaceutical industry plays an important role in the Polish

More information

INN Invented name Strengths Pharmaceutic al forms BEROTEC 0,5MG/10 ML. Partusisten intrapartal

INN Invented name Strengths Pharmaceutic al forms BEROTEC 0,5MG/10 ML. Partusisten intrapartal Annex I List of the names, pharmaceutical, strengths of the medicinal products, routes of, marketing authorisation s in the Member States 1 State (in INN Invented name Strengths Pharmaceutic al SCS Boehringer

More information

ALLEGATO 1 Prezzi. Prezzo in. ATC Principio Attivo

ALLEGATO 1 Prezzi. Prezzo in. ATC Principio Attivo ALLEGATO 1 Prezzi ATC Principio Attivo C07AB04 ACEBUTOLOLO 30 CPR.400 MG 7,50 M01AB16 ACECLOFENAC 30 BUST. 100 MG 8,09 M01AB16 ACECLOFENAC 40 CPR. 100 MG 10,80 J05AB01 ACICLOVIR 25 compresse 200 mg 11,29

More information

for Extended Stability Parenteral Drugs Third Edition Caryn M. Bing, R.Ph., M.S., FASHP Editor

for Extended Stability Parenteral Drugs Third Edition Caryn M. Bing, R.Ph., M.S., FASHP Editor Extended Stability for Parenteral Drugs Third Edition Editor Caryn M. Bing, R.Ph., M.S., FASHP 1 American Society of Health-System Pharmacists Bethesda, Maryland Contents Preface Acknowledgments x/ Dedication

More information

NDC HCPCS HCPCS Description NDC Description Effective Date End Date X-Over Only

NDC HCPCS HCPCS Description NDC Description Effective Date End Date X-Over Only Updated 5.5.14 NDC HCPCS HCPCS Description NDC Description Effective Date End Date X-Over Only 68152-0103-03 A9543 YTTRIUM Y-90 IBRITUMOMAB TIUXETAN ZEVALIN Y-90 VIAL 9/1/2013 12/31/2013 50419-0320-05

More information

Pharma working capital performance highly variable

Pharma working capital performance highly variable April 2014 Pharma working capital performance highly variable 41 Billion in Excess Working Capital We last completed this survey in 2012. We expected that there would be a broad improvement across the

More information

The European Ombudsman

The European Ombudsman Overview The European Ombudsman Е в р о п е й с к и о м б у д с м а н E l D e f e n s o r d e l P u e b l o E u r o p e o E v r o p s k ý v e ř e j n ý o c h r á n c e p r á v D e n E u r o p æ i s k e

More information

The power of creativity www.originbranding.com. Pharmaceutical Branding 2012

The power of creativity www.originbranding.com. Pharmaceutical Branding 2012 The power of creativity www.originbranding.com Pharmaceutical Branding 2012 We are an independent, boutique agency passionately focused on developing pharmaceutical brands. For over 15 years we have delivered

More information

Liofilchem - Antibiotic Disk Interpretative Criteria and Quality Control - F14013 - Rev.7 / 20.02.2013

Liofilchem - Antibiotic Disk Interpretative Criteria and Quality Control - F14013 - Rev.7 / 20.02.2013 Liofilchem Antibiotic Disk Interpretative Criteria and Quality Control F0 Rev.7 /.02. Amikacin AK Amoxicillin + Clavulanic acid AUG (+) ATCC 352 Coagulasenegative staphylococci Amoxicillin + Clavulanic

More information

Look-Alike Drug Names with Recommended Tall Man Letters

Look-Alike Drug Names with Recommended Tall Man Letters FDA and ISMP Lists of Look-Alike Drug Names with Recommended Tall Man Letters Since 2008, ISMP has maintained a list of drug name pairs and trios with recommended, bolded tall man (uppercase) letters to

More information

Asthma, COPD and Diabetes Preferred Drug List Medications

Asthma, COPD and Diabetes Preferred Drug List Medications GPI Name Dexamethasone Tab 0.5 MG Dexamethasone Tab 0.75 MG Dexamethasone Tab 1 MG Dexamethasone Tab 1.5 MG Dexamethasone Tab 2 MG Dexamethasone Tab 4 MG Dexamethasone Tab 6 MG Dexamethasone Elixir 0.5

More information

Clinical Case n. 3 Massimo Puoti AO Ospedale Niguarda Ca Granda Milano, Italy

Clinical Case n. 3 Massimo Puoti AO Ospedale Niguarda Ca Granda Milano, Italy Clinical Case n. 3 Massimo Puoti AO Ospedale Niguarda Ca Granda Milano, Italy Disclosures Member of advisory boards &/or speaker in own events &/or investigator in RCT &/or research grants &/or teacher

More information

Helstu breytingar á verðskrá ágúst 2011

Helstu breytingar á verðskrá ágúst 2011 Helstu breytingar á verðskrá ágúst 2011 Norrænt vheiti breytts lyfs Form Styrkur Magn ATC flokku Gamalt gildi Nýtt gildi Af undanþágulista 001574 Enalapril Mylan töflur 2,5 mg 50 stk C09AA02 1 Af viðmiðunarverðskrá

More information

Cloud Computing and Mobile Web Applications (120 ЕCTS)

Cloud Computing and Mobile Web Applications (120 ЕCTS) Study program Faculty Cycle Cloud Computing and Mobile Web Applications (120 ЕCTS) Contemporary Sciences and Technologies Postgraduate ECTS 120 Offered in Skopje Description of the program The study program

More information

Commercial Perspectives: Multiple Sclerosis

Commercial Perspectives: Multiple Sclerosis A Datamonitor Report Commercial Perspectives: Multiple Sclerosis How to Find Opportunities in an Unremitting Market Published: Jun-04 Product Code: Providing you with: In-depth profiles of current market-leading

More information

Problem A. Nanoassembly

Problem A. Nanoassembly Problem A. Nanoassembly 2.5 seconds One of the problems of creating elements of nanostructures is the colossal time necessary for the construction of nano-parts from separate atoms. Transporting each of

More information

Anatomical Therapeutic Chemical (ATC) classification and the Defined Daily Dose (DDD): principles for classifying and quantifying drug use

Anatomical Therapeutic Chemical (ATC) classification and the Defined Daily Dose (DDD): principles for classifying and quantifying drug use Anatomical Therapeutic Chemical (ATC) classification and the Defined Daily Dose (DDD): principles for classifying and quantifying drug use DRAFT Yong Chen Merck, Whitehouse Station, NJ USA Disclosure Author

More information

Advance IV Therapy Module. Example 1. 3mg. 3mg min = 45

Advance IV Therapy Module. Example 1. 3mg. 3mg min = 45 Advance IV Therapy Module Eample A patient is to receive Lidocaine at 3mg/. Supplied is a one liter bag of D 5 W containing Lidocaine 4g. Calculate the infusion rate in ml/. First, identify the doctor

More information

Uttag av läkemedel görs genom att anteckna i listan. Se rutinen!

Uttag av läkemedel görs genom att anteckna i listan. Se rutinen! Sjukhusapoteket Uppsala Sällanläkemedel 70-huset 1 (11) Sjukhusapoteket ank: 134 67 Gäller fr.o.m. Solveig Zettermark 6 maj 2014 Denna lista utgör aktuellt innehåll i Akademiska Sjukhusets förråd för Sällanläkemedel

More information

Chronic Fatigue Syndrome

Chronic Fatigue Syndrome 256 Srp Arh Celok Lek. 2011 Mar-Apr;139(3-4):256-261 ПРЕГЛЕД ЛИТЕРАТУРЕ / REVIEW ARTICLE DOI: 10.2298/SARH1104256B Chronic Fatigue Syndrome Snežana Brkić, Slavica Tomić, Maja Ružić, Daniela Marić Hospital

More information

Commercial Insight Osteoarthritis and Rheumatoid Arthritis

Commercial Insight Osteoarthritis and Rheumatoid Arthritis A Datamonitor In-Depth Analysis Commercial Insight Osteoarthritis and Rheumatoid Arthritis New Growth In A Mature Market Published: Jul-03 Product Code: DMHC1891 Why buy this analysis? Target current and

More information

Allegato 1 - Farmaci sottoposti a piano terapeutico LEGENDA PT GENERICO. piano terapeutico con template generico. PT SPECIFICO + nome principio attivo

Allegato 1 - Farmaci sottoposti a piano terapeutico LEGENDA PT GENERICO. piano terapeutico con template generico. PT SPECIFICO + nome principio attivo Allegato 1 - Farmaci sottoposti a piano terapeutico LEGENDA PT GENERICO PT SPECIFICO + nome principio attivo PT AIFA CONTINUITA' TERAPEUTICA H-T piano terapeutico con template generico piano terapeutico

More information

Directory of Generic Medications Eligible for Rx Savings Program Flat Fees

Directory of Generic Medications Eligible for Rx Savings Program Flat Fees Directory of Generic Medications Eligible for Rx Savings Program Flat Fees CONNECTICUT VERSION If you re already enrolled in the FREE* Rx Savings Program, use this guide to find your best choices. And,

More information

Decision Matrix: Selecting a CRM Vendor in the Pharmaceutical Market (Competitor Focus)

Decision Matrix: Selecting a CRM Vendor in the Pharmaceutical Market (Competitor Focus) A Datamonitor report Decision Matrix: Selecting a CRM Vendor in the Pharmaceutical Market (Competitor Focus) Published: Oct 07 Product Code: DMTC2133 Providing you with: Identifies which technology vendors

More information

FORMULARY. (List of Covered Drugs) Molina Dual Options Medicare-Medicaid Plan

FORMULARY. (List of Covered Drugs) Molina Dual Options Medicare-Medicaid Plan FORMULARY (List of Covered Drugs) 2015 Molina Dual Options Medicare-Medicaid Plan Version 14 UPDATED: 11/2015 Member Services (877) 901-8181, TTY/TDD 711 Monday - Friday, 8 a.m. - 8 p.m. local time H8046_15_16003_0002_MMPILRx

More information

April 10, 2008 Montana Healthcare Programs Update

April 10, 2008 Montana Healthcare Programs Update April 10, 2008 Montana Healthcare Programs Update THE FOLLOWING INFORMATION UPDATES AND REPLACES THE PROVIDER NOTICE DATED MARCH 10, 2008. NEW OR REVISED INFORMATION IS MARKED WITH A CHANGE BAR IN THE

More information

ehealthinsight Series: Online Patient Recruitment Strategies

ehealthinsight Series: Online Patient Recruitment Strategies A Datamonitor report ehealthinsight Series: Online Patient Recruitment Strategies Published: May-08 Product Code: Providing you with: Overview of benefits and drawbacks of online Analysis of online patient

More information

Chapter 7: Lung Cancer

Chapter 7: Lung Cancer Chapter 7: Lung Cancer Contents Chapter 7: Lung Cancer... 1 Small Cell... 2 Good PS + Limited stage... 2 Cisplatin/etoposide... 2 Concurrent chemotherapy + XRT... 2 Good / Intermediate PS... 2 Carboplatin

More information

HISTORY OF DEVELOPMENT CURRENT INDICATORS DEVELOPMENT PROSPECTS

HISTORY OF DEVELOPMENT CURRENT INDICATORS DEVELOPMENT PROSPECTS HISTORY OF DEVELOPMENT CURRENT INDICATORS DEVELOPMENT PROSPECTS 1. COMPANY DESCRIPTION Biocad is a Russian full cycle biotechnological company. It deals with development, manufacture and promotion of original

More information

Software and Hardware Systems for Abdominal Aortic Aneurysm Mechanical Properties Investigation

Software and Hardware Systems for Abdominal Aortic Aneurysm Mechanical Properties Investigation Ivan L. Milanković Nikola V. Mijailović Aleksandar S. Peulić Dalibor Nikolić Research and Development Center for Bioengineering BioIRC Igor Končar Clinical Center Serbia, Belgrade Themis Exarchos University

More information

ALLEGATO 5/A TECNICO

ALLEGATO 5/A TECNICO ALLEGATO 5/A TECNICO parte lasciata alla compilazione delle Ditte offerenti 1 2 3 4 5 1 A01AB Miconazolo os 2% 80g tb 2 A01AC Diflucortolone + josamicina os sol. muc.10ml flc 3 A01AD Cloromicetina digluconato

More information

Stakeholder Insight: Insulin Use in Type 2 Diabetes

Stakeholder Insight: Insulin Use in Type 2 Diabetes A Datamonitor Report Stakeholder Insight: Insulin Use in Type 2 Diabetes From Last Resort to Early Intervention Published: May-04 Product Code: DMHC1989 Providing you with: Analysis of Datamonitor s Diabetes

More information

Natural and Zn exchanged clinoptilolite: in situ high temperature XRD study of structural behavior and cation positions

Natural and Zn exchanged clinoptilolite: in situ high temperature XRD study of structural behavior and cation positions Bulgarian Chemical Communications, Volume 45, Number 4 (pp. 466 473) 2013 Natural and Zn exchanged clinoptilolite: in situ high temperature XRD study of structural behavior and cation positions L. T. Dimowa

More information

DPC 20151120 040321010 ONDANSETRONE SETOFILM*6FILMS ORODISP 4MG A04AA01 040321046 ONDANSETRONE SETOFILM*6FILMS ORODISP 8MG A04AA01

DPC 20151120 040321010 ONDANSETRONE SETOFILM*6FILMS ORODISP 4MG A04AA01 040321046 ONDANSETRONE SETOFILM*6FILMS ORODISP 8MG A04AA01 MINSAN Principio Attivo DESCRIZIONE ATC/CODICE COMPLEMENTA RE 040321010 ONDANSETRONE SETOFILM*6FILMS ORODISP 4MG A04AA01 040321046 ONDANSETRONE SETOFILM*6FILMS ORODISP 8MG A04AA01 027612074 ONDANSETRONE

More information

A POSSIBILITY OF SYNTHESIS OF HIGH-ALUMINA CEMENTS FROM DIFFERENT RAW MATERIALS

A POSSIBILITY OF SYNTHESIS OF HIGH-ALUMINA CEMENTS FROM DIFFERENT RAW MATERIALS Contemporary Materials, IV 1 (2013) Page 53 of 57 Professional papers UDK 66.017/.018+543.2/.9 doi : 10.7251/COMEN1301053L A POSSIBILITY OF SYNTHESIS OF HIGH-ALUMINA CEMENTS FROM DIFFERENT RAW MATERIALS

More information

Outcomes of Monitoring Committee Reviews. Medicines Australia Code of Conduct

Outcomes of Monitoring Committee Reviews. Medicines Australia Code of Conduct Outcomes of Monitoring Committee Reviews Medicines Australia Code of Conduct 1 Medicines Australia ABN 23 126 990 001 Level 1, 16 Napier Close Deakin ACT 2600 Phone: 02 6122 8500 Fax: 02 6122 8555 Web:

More information

Balloon Valvuloplasty as a Treatment of Congenital Aortic Stenosis in Children and Adolescents

Balloon Valvuloplasty as a Treatment of Congenital Aortic Stenosis in Children and Adolescents Srp Arh Celok Lek. 2014 Jan-Feb;142(1-2):17-22 DOI: 10.2298/SARH1402017P ОРИГИНАЛНИ РАД / ORIGINAL ARTICLE UDC: 616.132-007.271-089.819.1 17 Balloon Valvuloplasty as a Treatment of Congenital Aortic Stenosis

More information

Pharma working capital leaves room for improvement

Pharma working capital leaves room for improvement October 2012 Pharma working capital leaves room for improvement 50.7 Billion in Excess Working Capital Ten years ago it was not unusual to be asked why working capital mattered to a pharmaceutical company.

More information

3rd DVFA Life Science Conference 08 June 2010. Biosimilars. BIOCEUTICALS Arzneimittel AG. Epoetin zeta A case study

3rd DVFA Life Science Conference 08 June 2010. Biosimilars. BIOCEUTICALS Arzneimittel AG. Epoetin zeta A case study 3rd DVFA Life Science Conference 08 June 2010 Biosimilars BIOCEUTICALS Arzneimittel AG Epoetin zeta A case study Dr. Michael Mack Member of Executive Board BIOCEUTICALS Arzneimittel AG BIOCEUTICALS Arzneimittel

More information

AETNA BETTER HEALTH OF OHIO a MyCare Ohio plan

AETNA BETTER HEALTH OF OHIO a MyCare Ohio plan AETNA BETTER HEALTH OF OHIO a MyCare Ohio plan 2015 List of Covered Drugs/Formulary Aetna Better Health of Ohio, a MyCare Ohio plan (Medicare-Medicaid Plan) is a health plan that contracts with Medicare

More information

COMPLIANCE OF MANAGEMENT ACCOUNTING WHEN USING INFORMATION TECHNOLOGIES

COMPLIANCE OF MANAGEMENT ACCOUNTING WHEN USING INFORMATION TECHNOLOGIES Margaryta I. Skrypnyk, Mykola M. Matiukha COMPLIANCE OF MANAGEMENT ACCOUNTING WHEN USING INFORMATION TECHNOLOGIES The article studies the correspondence of management accounting structure when using of

More information

Global Forum on Competition

Global Forum on Competition s Unclassified DAF/COMP/GF/WD(2014)39 DAF/COMP/GF/WD(2014)39 Unclassified Organisation de Coopération et de Développement Économiques Organisation for Economic Co-operation and Development 04-Feb-2014

More information

PROJECT LIST GENERIC PRODUCTS

PROJECT LIST GENERIC PRODUCTS PROJECT LIST GENERIC PRODUCTS Acetylcysteine, Effervescent tablets 200 mg, 600 mg Alendronate sodium, Tablets 10, 70 mg Alfuzosin,Tablets 2.5mg Alfuzosin, ER Tablets 10 mg Ambroxol, Effervescent tablets

More information

PRONTUARIO TERAPEUTICO AZIENDALE A.O. LEGNANO

PRONTUARIO TERAPEUTICO AZIENDALE A.O. LEGNANO A.T.C. PRINCIPIO ATTIVO DOSAGGIO TOTALE della forma farmaceutica FORMA FARMACEUTICA A- APPARATO GASTROINTESTINALE A01AB03 clorexidina 200MG/ML 150 ML SOLUZ. MUCOSA ORALE A01AB09 miconazolo 2% GEL ORALE

More information

Palliative Coverage Drug Benefit Supplement

Palliative Coverage Drug Benefit Supplement Palliative Coverage Drug Benefit Supplement Effective April 1, 2015 Inquiries should be directed to: Pharmacy Services Alberta Blue Cross 10009 108 Street NW Edmonton AB T5J 3C5 Telephone Number: (780)

More information

Allergy Emergency Treatment Protocol

Allergy Emergency Treatment Protocol Allergy Emergency Treatment Protocol I. Initial evaluation of possible allergic reaction a. Cease administration of allergenic extracts b. Notify physician c. Record vital signs: blood pressure, pulse,

More information

Novo Nordisk Patient Assistance Program P.O. Box 181640 Louisville, KY 40261 866-310-7549 Fax: 866-441-4190

Novo Nordisk Patient Assistance Program P.O. Box 181640 Louisville, KY 40261 866-310-7549 Fax: 866-441-4190 Novo Nordisk Patient Assistance Program P.O. Box 181640 Louisville, KY 40261 866-310-7549 Fax: 866-441-4190 The Novo Nordisk Patient Assistance Program provides medication to qualifying applicants at no

More information

The legally binding text is the original French version TRANSPARENCY COMMITTEE OPINION. 10 March 2010

The legally binding text is the original French version TRANSPARENCY COMMITTEE OPINION. 10 March 2010 The legally binding text is the original French version TRANSPARENCY COMMITTEE OPINION 10 March 2010 ARIXTRA 1.5 mg/0.3 ml, solution for injection in pre-filled syringe Box of 2 (CIP: 363 500-6) Box of

More information

PG Diploma in Clinical Research, Pharmacovigilance, Regulatory and Clinical Data Management

PG Diploma in Clinical Research, Pharmacovigilance, Regulatory and Clinical Data Management PG Diploma in Clinical Research, Pharmacovigilance, Regulatory and Clinical Data Management Contact: +91 9886735658, 080 28411665 ext 5103 Email: crtraining@avesthagen.com PG Diploma In Clinical Research,

More information

Common Drug Review Pharmacoeconomic Review Report

Common Drug Review Pharmacoeconomic Review Report Common Drug Review Pharmacoeconomic Review Report August 2015 Drug rivaroxaban (Xarelto) Indication Listing request Manufacturer Treatment of venous thromboembolic events (deep vein thrombosis [DVT], pulmonary

More information

PEDAGOGICAL UPTAKE OF TECHNOLOGY IN E-LEARNING FOR LANGUAGES: THE CASE OF NBU MOODLE

PEDAGOGICAL UPTAKE OF TECHNOLOGY IN E-LEARNING FOR LANGUAGES: THE CASE OF NBU MOODLE PEDAGOGICAL UPTAKE OF TECHNOLOGY IN E-LEARNING FOR LANGUAGES: THE CASE OF NBU MOODLE Stanislav Bogdanov, New Bulgarian University Резюме Статията представя проучване, проведено през учебната 2010-2011

More information

Stakeholder Insight: Multiple Sclerosis Disease-modifying Efficacy and Side Effects Guide Treatment Choice

Stakeholder Insight: Multiple Sclerosis Disease-modifying Efficacy and Side Effects Guide Treatment Choice A Datamonitor report Stakeholder Insight: Multiple Sclerosis Disease-modifying Efficacy and Side Effects Guide Treatment Choice Published: Dec-06 Product Code: Providing you with: An overview of epidemiology,

More information

Stakeholder Perspectives: Mild Cognitive Impairment and Dementia

Stakeholder Perspectives: Mild Cognitive Impairment and Dementia A Datamonitor In-Depth Analysis Stakeholder Perspectives: Mild Cognitive Impairment and Dementia Aricept in Race to Pioneer Unexplored Markets Published: Aug-03 Product Code: DMHC1924 Why buy this analysis?

More information

Autism Spectrum Disorder Formulation & Resource Guide

Autism Spectrum Disorder Formulation & Resource Guide Autism Spectrum Disorder Formulation & Resource Guide Autism Spectrum Disorder Formulation & Resource Guide Knowledge Changes Everything: Quality. Innovation. Experience. Since 1974. 2015 College Pharmacy

More information

KEEPING CLINICAL TRIALS IN AUSTRALIA

KEEPING CLINICAL TRIALS IN AUSTRALIA OCCASIONAL PAPER SERIES KEEPING CLINICAL TRIALS IN AUSTRALIA WHY ACTION IS NEEDED NOW OCCASIONAL PAPER SERIES > Medicines Australia is producing Occasional Papers to promote a contest of ideas, thought

More information

THE ROYAL CORNWALL HOSPITALS NHS TRUST RESPONSE TO INFORMATION REQUEST. Date Request Received: 03 August 2015 FOI Ref: 947

THE ROYAL CORNWALL HOSPITALS NHS TRUST RESPONSE TO INFORMATION REQUEST. Date Request Received: 03 August 2015 FOI Ref: 947 FREEDOM OF INFORMATION ACT 2000 THE ROYAL CORNWALL HOSPITALS NHS TRUST RESPONSE TO INFORMATION REQUEST Date Request Received: 03 August 2015 FOI Ref: 947 Requested Information For the Royal Cornwall Hospitals

More information

Emergency Medical Items Catalogue 2002. Code Description Ind. price Ship. weight Ship. Vol.

Emergency Medical Items Catalogue 2002. Code Description Ind. price Ship. weight Ship. Vol. Injectable drugs DINJACSA5V ACETYLSALICYLAT LYSINE, 0.9 g (aspirin 0.5 g), powder vial Injectable analgesic, antipyretic, anti inflammatory. Not in the WHO Essential Medicines list 2002. Action is rapid,

More information

LISTADO DE MEDICAMENTOS CON SUSTANCIAS INCLUIDAS EN RESOLUCION DOPAJE VIGENTE

LISTADO DE MEDICAMENTOS CON SUSTANCIAS INCLUIDAS EN RESOLUCION DOPAJE VIGENTE LISTADO DE MEDICAMENTOS CON SUSTANCIAS INCLUIDAS EN RESOLUCION DOPAJE VIGENTE Medicamentos con sustancias descritas en la Resolución de 18 de diciembre de 2014 de la Presidencia del Consejo Superior de

More information

ATC/DDD Classification

ATC/DDD Classification ATC/DDD Classification ATC/DDD Classification (Temporary) The following ATC codes, DDDs and alterations were agreed at the meeting of the WHO International Working Group for Drug Statistics Methodology

More information

Dosage Calculations INTRODUCTION. L earning Objectives CHAPTER

Dosage Calculations INTRODUCTION. L earning Objectives CHAPTER CHAPTER 5 Dosage Calculations L earning Objectives After completing this chapter, you should be able to: Solve one-step pharmaceutical dosage calculations. Set up a series of ratios and proportions to

More information

Preferentiematrix per stofnaam / per verzekeraar / per 1 juli 2015 (voor zover bekend en bijgewerkt per 30 juni 2015) 1/9

Preferentiematrix per stofnaam / per verzekeraar / per 1 juli 2015 (voor zover bekend en bijgewerkt per 30 juni 2015) 1/9 Preferentiematrix per stofnaam / per verzekeraar / per 1 juli 2015 (voor zover bekend en bijgewerkt per 30 juni 2015) 1/9 STOFNAAM MG/mcg AGIS/ACHMEA CZ groep MENZIS VGZ/Univé ATC code VERZEKERAAR UZOVI

More information

Joanne Petruso RN, MSN

Joanne Petruso RN, MSN Joanne Petruso RN, MSN Office Address: Nevada Access to Research and Education Society Wellness Center Nevada AIDS Research and Education Society 2300 S. Rancho Dr. 2300 S. Rancho Dr., Suite #203 Suite

More information

Applications for new human medicines under evaluation by the Committee for Medicinal Products for Human Use

Applications for new human medicines under evaluation by the Committee for Medicinal Products for Human Use 25 April 2014 EMA/237058/2014 Procedure Management and Business Support Division Applications for new human under evaluation by the Committee for Medicinal Products for Human Use April 2014 This document

More information

Steroid treatment in cystic fibrosis

Steroid treatment in cystic fibrosis Steroid treatment in cystic fibrosis Factsheet March 2013 Steroid treatment in cystic fibrosis Introduction This factsheet contains information on steroid treatment in cystic fibrosis, including the different

More information

e-labeling : innovation for patient or regulation nightmare Pharmapack Feb, 11 th, 2015

e-labeling : innovation for patient or regulation nightmare Pharmapack Feb, 11 th, 2015 e-labeling : innovation for patient or regulation nightmare Pharmapack Feb, 11 th, 2015 PHARMAPACK 2015 1 Mobile health x2 30 months 100 000 mapps Source: research2guidance, mhealth App Market Report 2013-2017

More information

Common medicines given to neurosurgery patients on discharge from hospital

Common medicines given to neurosurgery patients on discharge from hospital Common medicines given to neurosurgery patients on discharge from hospital This leaflet contains brief information about some of the medicines we commonly supply on discharge to patients who have been

More information

Emergency Medications Approved for Use at VAPAHCS

Emergency Medications Approved for Use at VAPAHCS Table 1: Medications (PAD GM&S) Emergency Medications Approved for Use at VAPAHCS PAD GM&S (See HCSM 11-12-35 Attachment A CPR Committee Atropine 1mg/10ml syringe X 3 Normal saline 1000ml bag X 2 Sodium

More information

Information for Vermont Prescribers of Prescription Drugs (Long Form)

Information for Vermont Prescribers of Prescription Drugs (Long Form) The information on this form is provided pursuant to Vermont law 33 V.S.A. section 2005a which requires this disclosure by pharmaceutical marketers. Information for Vermont Prescribers of Prescription

More information

YouTube and political communication Macedonian case

YouTube and political communication Macedonian case www.ijcsi.org 460 YouTube and political communication Macedonian case MSc. Sali Emruli 1, Mr.Tahir Zejneli 2, MSc. Florin Agai 3 Faculty of Organization and Informatics, University of Zagreb, Varaždin,

More information

THE POSSIBILITY OF EDUCATION ABOUT RELIGIOUS CULTURE IN PUBLIC SCHOOLS

THE POSSIBILITY OF EDUCATION ABOUT RELIGIOUS CULTURE IN PUBLIC SCHOOLS Originalni naučni rad Inoue Nobutaka 1 UDK: 37.032:2(520) THE POSSIBILITY OF EDUCATION ABOUT RELIGIOUS CULTURE IN PUBLIC SCHOOLS I Recent Argument on Religious Education in Japan Arguments on religious

More information

CHEM-E4140 Selectivity 12. Pharma Business

CHEM-E4140 Selectivity 12. Pharma Business CHEM-E4140 Selectivity 12. Pharma Business Prof. Ari Koskinen Laboratory of Organic Chemistry C318 Pharma Business Total volume ca 1100 G$ (Shell 421G$; Walmart 486G$; Toyota 252 G$). Annually approx 25

More information

Legal and Ethical Veterinary Compounding. Scott D. Stanley, Ph.D., Professor University of California, Davis School of Veterinary Medicine

Legal and Ethical Veterinary Compounding. Scott D. Stanley, Ph.D., Professor University of California, Davis School of Veterinary Medicine Legal and Ethical Veterinary Compounding Scott D. Stanley, Ph.D., Professor University of California, Davis School of Veterinary Medicine American Association of Equine Practitioners 2009 Equine Chemistry

More information

Confidence that comes from experience!

Confidence that comes from experience! Confidence that comes from experience! ABOUT DGMP GROUP Starting from 1979 the DGMP Group has been organising successfully international and national events. The Group has focused primarily on customer

More information

Package Leaflet: Information for the user

Package Leaflet: Information for the user Package Leaflet: Information for the user Actrapid 100 IU/ml solution for injection in vial Insulin human (rdna) Read all of this leaflet carefully before you start using your insulin Keep this leaflet.

More information

LEAD DISTRIBUTION IN SOIL DUE TO LITHOGENIC AND ANTHROPOGENIC FACTORS IN THE BREGALNICA RIVER BASIN

LEAD DISTRIBUTION IN SOIL DUE TO LITHOGENIC AND ANTHROPOGENIC FACTORS IN THE BREGALNICA RIVER BASIN 289 Geologica Macedonica, Vol. 29, No. 1, pp. 53 61 (2015) GEOME 2 In print: ISSN 0352 1206 Manuscript received: Април 1, 2015 On line: ISSN 1857 8586 Accepted: Април 30, 2015 UDC: 504.3:622.343.445(497.73)

More information

$4, 30-day $10, 90-day

$4, 30-day $10, 90-day $4 Prescriptions - Choose from hundreds of generic drugs and over the counter medications. Free Home Delivery Mailed right to your home Free shipping Prescription Program includes up to a 30-day supply

More information

Joong-Seok Cho 1 THE RELATION BETWEEN ACCOUNTING QUALITY AND SECURITY ANALYSTS' TARGET PRICE FORECAST PERFORMANCE

Joong-Seok Cho 1 THE RELATION BETWEEN ACCOUNTING QUALITY AND SECURITY ANALYSTS' TARGET PRICE FORECAST PERFORMANCE НОВИНИ СВІТОВОЇ НАУКИ 503 Joong-Seok Cho 1 THE RELATION BETWEEN ACCOUNTING QUALITY AND SECURITY ANALYSTS' TARGET PRICE FORECAST PERFORMANCE Using a sample of the US security analysts' target price forecasts

More information

Date: November 30, 2010

Date: November 30, 2010 Department of Health and Human Services Public Health Service Food and Drug Administration Center for Drug Evaluation and Research Date: November 30, 2010 To: Through: From: Subject: Drug Name(s): Application

More information